Systolic versus diastolic blood pressure versus pulse pressure

Current Cardiology Reports

Volumn 4, Issue 6, 2002, Pages 463-467

  White, William B ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIASTOLE; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SYSTOLE;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; DIASTOLE; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; PULSE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SYSTOLE;

EID: 0036831594     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-002-0107-4     Document Type: Article

References (30)

1. Stamler J, Stamler R, Neaton J: Blood Pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993, 153:598-615.
2. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The 6th report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997, 157:2413-2446.
3. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255-3264.
4. Staessen JA, Fagard R, Thijs L, et al., for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997, 350:757-764.
5. Vardan S, Mookherjee S: Perspective on isolated systolic hypertension in elderly patients. Arch Fam Med 2000, 9:319-323.
6. White WB: Benefits of antihypertensive therapy in older patients with hypertension. Arch Intern Med 2000, 160:149-150.
7. Smulyan H, Safar ME: The diastolic blood pressure in systolic hypertension. Ann Intern Med 2000, 32:233-237.
8. Domanski MJ, Davis BR, Pfeffer MA, et al.: Isolated systolic hypertension: Prognostic information provided by pulse pressure. Hypertension 1999, 34:375-380.
9. Franklin SS, Sutton-Tyrell K, Belle SH, et al.: The importance of pulsatile components of hypertension in predicting carotid stenosis in older adults. J Hypertens 1997, 15:1143-1150.
10. Vaccarino V, Holford TR, Krumholz HM: Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol 2000, 36:130-136.
11. Benetos A, Safar M, Rudnichi A, et al.: Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997, 30:1410-1415.
12. Blacher J, Staessen JA, Girerd X, et al.: Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000, 160:1085-1089.
13. Antikainen RL, Jousilahti P, Vanhanen H, Ruomilehto J: Excess mortality associated with increased pulse pressure among middle-aged men and women is explained by high systolic blood pressure. J Hypertens 2000, 18:417-423.
14. Benetos A, Zureik M, Morcet J, et al.: A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol 2000, 35:673-680.
15. Staessen JA, Gasowski J, Wang JG, et al.: Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000, 11:865-872.
16. Port S, Demer L, Jennrich R, et al.: Systolic blood pressure and mortality. Lancet 2000, 355:175-180.
17. Staessen JA, Thijs L, Fagard R, et al.: Predicting cardiovascular risk using conventional versus ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999, 282:539-546.
18. Verdecchia P, Schillaci G, Borgioni C, et al.: Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension. Hypertension 1998, 32:983-988.
19. Cruickshank JM: Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ 1988, 297:1227-1230.
20. Black HR, Elliott WJ, Neaton JD, et al.: Baseline characteristics and early blood pressure control in the CONVINCE trial. Hypertension 2001, 37:12-18.
21. Hansson L, Zanchetti A, Carruthers SG, et al.: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998, 351:1755-1762.
22. ALLHAT Collaborative Research Group: Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorhtalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000, 283:1967-1975.
23. Prisant LM, Moser M: Hypertension in the elderly: can we improve results of therapy? Arch Intern Med 2000, 160:283-289.
24. Bohmer F, Baronch R, Reinfruk J: Treatment of isolated systolic hypertension in the elderly with verapamil slow-release 240 mg. J Cardiovasc Pharmacol 1998, 12(Suppl 4):S45-S46.
25. Stallard MP, Park GD, Stewart WH: Systolic blood pressure response in three subgroups of hypertensives treated with sustained release diltiazem. J Cardiovasc Pharmacol 1998, 12(Suppl 6):S117-S119.
26. Leonetti G, Trimarco B, Collatina S: An effective approach for treating elderly patients with isolated systolic hypertension: results of an Italian multicenter study with fosinopril. Am J Hypertens 1997, 10(Suppl):230S-235S.
27. Giles TD, Weber M, Bartels DW: Treatment of isolated systolic hypertension with labetalol in the elderly. Arch Intern Med 1990, 150:974-976.
28. Epstein M, Menard J, Alexander J, Roniker B: Eplerenone, a novel and selective aldosterone receptor antagonist: efficacy in patients with mild to moderate hypertension [abstract]. Circulation 1998, 98:I-98-I-99.
29. Weber M: Emerging treatments for hypertension: potential role for vasopeptidase inhibition. Am J Hypertens 1999, 12:139S-147S.
30. White WB: The systolic pressure versus pulse pressure controversy. Am J Cardiol 2001, 87:1278-1281.